{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:55:49Z","timestamp":1778806549611,"version":"3.51.4"},"reference-count":66,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2320-B-016-017-MY3"],"award-info":[{"award-number":["MOST 105-2320-B-016-017-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cisplatin is still the primary therapeutic choice for advanced lung cancers without driver mutations. The occurrence of cisplatin resistance is a major clinical problem in lung cancer treatment. The natural extracted agent emetine reportedly has anticancer effects. This study aimed to explore the possible role of emetine in cisplatin resistance. We used cell viability, Western blot, and Wnt reporter assays to show that emetine suppresses proliferation, \u03b2-catenin expression, and Wnt\/\u03b2-catenin signaling in non-small cell lung cancer (NSCLC). The synergism of emetine and cisplatin was assessed by constructing isobolograms and calculating combination index (CI) values using the Chou-Talalay method. Emetine effectively synergized with cisplatin to suppress the proliferation of cancer cells. Furthermore, nuclear \u03b2-catenin and cancer stem cell-related markers were upregulated in the cisplatin-resistant subpopulation of CL1-0 cells. Emetine enhanced the anticancer efficacy of cisplatin and synergized with cisplatin in the cisplatin-resistant subpopulation of CL1-0 cells. Taken together, these data suggest that emetine could suppress the growth of NSCLC cells through the Wnt\/\u03b2-catenin pathway and contribute to a synergistic effect in combination with cisplatin.<\/jats:p>","DOI":"10.3390\/ijms20235914","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T11:12:21Z","timestamp":1574680341000},"page":"5914","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-040X","authenticated-orcid":false,"given":"Ti-Hui","family":"Wu","sequence":"first","affiliation":[{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan"},{"name":"Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-174X","authenticated-orcid":false,"given":"Shan-Yueh","family":"Chang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan"},{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-4393","authenticated-orcid":false,"given":"Yu-Lueng","family":"Shih","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan"},{"name":"Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Wang","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-7941","authenticated-orcid":false,"given":"Ya-Wen","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan"},{"name":"Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tieche, C.C., Peng, R.W., Dorn, P., Froment, L., Schmid, R.A., and Marti, T.M. (2016). Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2117-4"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: Mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.1998.16.6.2133","article-title":"Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"16","author":"Giaccone","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gao, J., Meng, Q., Zhao, Y., Chen, X., and Cai, L. (2016). EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2527-3"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2016.03.006","article-title":"NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt\/beta-catenin signaling pathway","volume":"376","author":"Peng","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hubaux, R., Thu, K.L., and Lam, W.L. (2014). Re: The Wnt signaling pathway in non-small cell lung cancer. J. Natl. Cancer Inst., 106.","DOI":"10.1093\/jnci\/dju188"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the Wnt\/beta-catenin pathway in cancer: Update on effectors and inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.18632\/oncotarget.3609","article-title":"Fibulin-5 inhibits Wnt\/beta-catenin signaling in lung cancer","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1038\/ncomms9640","article-title":"Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt\/beta-catenin signalling","volume":"6","author":"Fang","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/onc.2009.82","article-title":"Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma","volume":"28","author":"Akiri","year":"2009","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2016.11.038","article-title":"Wnt\/beta-catenin pathway mediates (\u2212)\u2212Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells","volume":"482","author":"Zhu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wu, J.Y., Shih, Y.L., Lin, S.P., Hsieh, T.Y., and Lin, Y.W. (2019). YC-1 Antagonizes Wnt\/beta-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma. Cancers (Basel), 11.","DOI":"10.3390\/cancers11050661"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1874848101104010008","article-title":"Biological activities of emetine","volume":"4","author":"Akinboye","year":"2011","journal-title":"Open Nat. Prod. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/1097-0142(197104)27:4<835::AID-CNCR2820270413>3.0.CO;2-K","article-title":"Experience with emetine hydrochloride (NSC 33669) as an antitumor agent","volume":"27","author":"Panettiere","year":"1971","journal-title":"Cancer"},{"key":"ref_17","first-page":"737","article-title":"The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells","volume":"18","author":"Moller","year":"2007","journal-title":"Oncol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1055\/s-2007-990229","article-title":"Characteristics of apoptosis induction by the alkaloid emetine in human tumour cell lines","volume":"73","author":"Moller","year":"2007","journal-title":"Planta Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3892\/ijo.2014.2703","article-title":"The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL","volume":"46","author":"Sun","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Davidson, V.J., Patel, D., Flanigan, R., Gupta, G.N., and Foreman, K.E. (2017). Emetine reduces the effective dose of cisplatin or carboplatin required to inhibit bladder cancer cell proliferation. Bladder, 4.","DOI":"10.14440\/bladder.2017.570"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cbi.2015.08.014","article-title":"Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways","volume":"242","author":"Kim","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/1097-0142(197305)31:5<1170::AID-CNCR2820310520>3.0.CO;2-4","article-title":"A phase I study of emetine hydrochloride (NSC 33669) in solid tumors","volume":"31","author":"Mastrangelo","year":"1973","journal-title":"Cancer"},{"key":"ref_25","first-page":"423","article-title":"Phase II study of emetine (NSC-33669) in the treatment of solid tumors","volume":"57","author":"Siddiqui","year":"1973","journal-title":"Cancer Chemother. Rep."},{"key":"ref_26","first-page":"1171","article-title":"Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma","volume":"59","author":"Kane","year":"1975","journal-title":"Cancer Chemother. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF00334453","article-title":"Experimental emetine myopathy: Enzyme histochemical, electron microscopic, and immunomorphological studies","volume":"85","author":"Hopf","year":"1993","journal-title":"Acta Neuropathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0300-483X(94)02928-N","article-title":"Effects of pharmacological interventions on emetine cardiotoxicity in isolated perfused rat hearts","volume":"97","author":"Pan","year":"1995","journal-title":"Toxicology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1385\/CT:3:4:311","article-title":"Emetine inhibits glycolysis in isolated, perfused rat hearts","volume":"3","author":"Pan","year":"2003","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Barr, M.P., Gray, S.G., Hoffmann, A.C., Hilger, R.A., Thomale, J., O\u2019Flaherty, J.D., Fennell, D.A., Richard, D., O\u2019Leary, J.J., and O\u2019Byrne, K.J. (2013). Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054193"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1158\/0008-5472.CAN-04-4453","article-title":"Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors","volume":"65","author":"Chau","year":"2005","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/np050029m","article-title":"Terpenoid Tetrahydroisoquinoline Alkaloids Emetine, Klugine, and Isocephaeline Inhibit the Activation of Hypoxia-Inducible Factor-1 in Breast Tumor Cells","volume":"68","author":"Zhou","year":"2005","journal-title":"J. Nat. Prod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnci\/djk196","article-title":"Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non\u2013Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis","volume":"99","author":"Ardizzoni","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-319-24223-1_10","article-title":"Chemotherapy Resistance in Lung Cancer","volume":"893","author":"Kim","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fong, W., and To, K.K.W. (2019). Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cell. Mol. Life Sci.","DOI":"10.1007\/s00018-019-03134-0"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"djt356","DOI":"10.1093\/jnci\/djt356","article-title":"Wnt signaling pathway in non-small cell lung cancer","volume":"106","author":"Stewart","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.21037\/tlcr.2016.08.08","article-title":"Prognostic value of wingless-type proteins in non-small cell lung cancer patients: A meta-analysis","volume":"5","author":"Jin","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_40","first-page":"203","article-title":"Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients","volume":"19","author":"Nakashima","year":"2008","journal-title":"Oncol. Rep."},{"key":"ref_41","first-page":"586","article-title":"The correlation between the expression of Wnt1 and prognosis in resected non-small cell lung cancer","volume":"13","author":"Wang","year":"2010","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e31820c5189","article-title":"Aberrant Wnt1\/beta-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery","volume":"6","author":"Xu","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/SLA.0b013e31826d81fd","article-title":"Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer","volume":"257","author":"Shapiro","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2009.04.030","article-title":"WNT\/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis","volume":"138","author":"Nguyen","year":"2009","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/carcin\/bgu034","article-title":"Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients","volume":"35","author":"Coscio","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_46","first-page":"5856","article-title":"Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt\/beta-catenin signaling pathway","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lfs.2018.07.023","article-title":"BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via beta-catenin pathway","volume":"208","author":"Zhang","year":"2018","journal-title":"Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.biopha.2018.10.042","article-title":"SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma","volume":"109","author":"He","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1002\/jcb.27851","article-title":"Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt\/beta-catenin pathway in prostate cancer","volume":"120","author":"Jiang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.18632\/oncotarget.27008","article-title":"PARP-1 inhibitor modulate beta-catenin signaling to enhance cisplatin sensitivity in cancer cervix","volume":"10","author":"Mann","year":"2019","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Milosevic, V., Kopecka, J., Salaroglio, I.C., Libener, R., Napoli, F., Izzo, S., Orecchia, S., Ananthanarayanan, P., Bironzo, P., and Grosso, F. (2019). Wnt\/IL-1beta\/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. Int. J. Cancer.","DOI":"10.1002\/ijc.32419"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.omto.2019.04.002","article-title":"Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt\/beta-Catenin Signaling in Ovarian Cancer","volume":"14","author":"Ruan","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.biopha.2018.10.080","article-title":"MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating beta-catenin signaling in cisplatin-resistant colorectal cancer cells","volume":"109","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shi, S.L., and Zhang, Z.H. (2019). Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p\/Wnt\/beta-catenin pathway. Neoplasma.","DOI":"10.4149\/neo_2018_181218N980"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wang, L., Sun, J., Gao, P., Su, K., Wu, H., Li, J., and Lou, W. (2019). Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1\/TEAD1\/GLUT1 pathway. J. Cell. Physiol.","DOI":"10.1002\/jcp.28253"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cbi.2019.05.032","article-title":"HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma","volume":"308","author":"Wu","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1690896","DOI":"10.1155\/2016\/1690896","article-title":"Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a\/PKC Signaling Pathway","volume":"2016","author":"Yang","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3892\/mmr.2016.4882","article-title":"beta-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"94317","DOI":"10.18632\/oncotarget.21693","article-title":"MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3892\/mmr.2017.6170","article-title":"Sox2 inhibits Wnt-beta-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells","volume":"15","author":"He","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2018.10.001","article-title":"NEAT1 contributes to the CSC-like traits of A549\/CDDP cells via activating Wnt signaling pathway","volume":"296","author":"Jiang","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/ng.3990","article-title":"Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers","volume":"49","author":"Blakely","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2010.01.028","article-title":"Wnt\/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells","volume":"392","author":"Teng","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"C709","DOI":"10.1152\/ajpcell.00212.2015","article-title":"The emerging roles of Oct4 in tumor-initiating cells","volume":"309","author":"Wang","year":"2015","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wang, P., Gao, Q., Suo, Z., Munthe, E., Solberg, S., Ma, L., Wang, M., Westerdaal, N.A., Kvalheim, G., and Gaudernack, G. (2013). Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057020"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zhang, X., Liu, G., Kang, Y., Dong, Z., Qian, Q., and Ma, X. (2013). N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057692"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/23\/5914\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:37:18Z","timestamp":1760189838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/23\/5914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":66,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["ijms20235914"],"URL":"https:\/\/doi.org\/10.3390\/ijms20235914","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]}}}